A new branch of medicine?
We didn’t want to invent a new branch of medicine
PhotoMed’s vision was to develop a practical, non-invasive means for ending unrelenting pain and its impairments. Inventing the therapy was the easy part.
Testing PhotoMed’s therapy yielded surprises. The crazy fast and HUGE responses puzzled our anesthesiologist and neurologist advisors. They wondered if something special might be happening. For 18 years, we collected real-time data as real-world people responded to the new therapy, or not.
Today, our team of software engineers builds tools that prompt and record details while impaired functions switch back to normal.
Could the switch-back-to-normal function open a new branch in medicine?
Would you expect “managed” pain to end while you watch?
Could the switch-back-to-normal function be the last step and waiting for a signal to get going again?
Unfortunately, well-managed pain doesn’t appear to respond so quickly to PhotoMed’s therapy.
The switching “event” appears to be the same for the sensory, motor, and skin temperature regulation systems.
Could the photons of varying wavelengths be acting like a signal or catalyst? The body does the rest. How many events would you like to watch?
The healing effects of light have long been recognized.
A Nobel Prize in Medicine
Dr. Finsen was awarded a Nobel Prize in Medicine in 1903, for his use of blue wavelengths that stimulates nerves. Red had already been found to relieve other types of pain.
Is it 1, 2, or a sequence of wavelengths for treatment-resistant pain?
PhotoMed’s Vari-Chrome® Pro prompts the body to do what it had been trying to do by the body switching back to normal. Nothing more. Nothing special, like opioids.
Documenting responses and outcomes in real time
PhotoMed’s Instant Verification System™ documents the responses and outcomes. The physician uses information from the System in real time to make treatment decisions during each visit. The patient’s report of pain relief frequently happens after visit.
For people with pain that hasn’t been relieved by interventions
This may seem to be a new branch of medicine because the pain that resolves has been treatment resistant. The people with pain that isn’t expected to respond are typically excluded from conventional studies.
3242 recordings from 6 unrelated clinics with doctors, including anesthesiologists and neurologists who freely volunteered (we are frugal) to test the therapy for their patients. The studies lasted from 1 to 8 years.
They reported that the therapy worked in 28 to 35% of cases depending on the disorder. We couldn’t push the ratio further for the past 3 years.
My family and I funded this discovery process with $20M from my successful exit from the prior company that I founded.
(It would have cost $100m for Pfizer to do this. This would be a tiny amount compared with the $700B pain market. Of course, they didn’t because you can’t make billions from humble photons. Especially, if the photons bombard your revenue stream of very expensive pain medication that people must stay on forever.)
With the discovery and development trials complete, the algorithm has been defined. The Triple 2 Algorithm focuses on failure because that saves time and money when there is no response.
Now, it’s time to take the technology from lab to doctor’s offices country-wide. The cost will be at least $10M to scale.
For professional and financial reasons, as a not-so-young research scientist, I am not the right person to now get this in every doctor’s office.
Perhaps you are one of the people who benefitted from the therapy. Perhaps now your fingers or feet feel normal again. Move normally again. Or, don’t feel like ice.
You can help bring the care to scale by funding the company and people who have already brought medical devices to market and obtain equity.
Questions? Comments? Drop me a line at email@example.com.
+ Allan's Bio
I founded Kensington Laboratories in my garage in 1972. Kensington Laboratories manufactured precision robots and measuring tools. The robots enabled Intel and other Silicon Valley companies to make computer chips with fewer defects going from one-in-a-million to 1-in-a-bilion. And, to chase Moore’s faster, better, cheaper Law.
After 25 years, I finally collapsed from chasing Moore’s Law. The company I founded later exited for $320M.
Having nothing to do, exhausted, and in poor health, I turned to medicine to fix my problems. Because I believe in machine learning and outcome-based results, I tried everything. One day, I was even in a light therapist’s office. He showed me that Dr. Finsen was awarded a Nobel Prize in Medicine in 1903 for blue and red light. I was surprised. He said, do you think they give the Nobel Prize for things that don’t work? With the Nobel Prize, I didn’t wonder IF red and blue worked.
As an optics guy, I asked, what about the 282 wavelengths in between? He answered, nobody knows because no one has studied them. I was puzzled. If red works and blue works, as an optics guy, I could not understand why no one had looked. Fine, let me look at that tonight.
I told him that I could find out in a week what the other wavelengths might do using the tools that I developed for Intel. It turned out to be more challenging that I thought. Fortunately, I had my exit capital to found PhotoMed Technologies. After 18 years in stealth research mode, the thing finally came full circle.
All the wavelengths do something for someone. The problem is which wavelength for whom. Of course, it doesn’t work as well for people with hormone imbalances, Parkinson’s, or fix bio-mechanical problems, like bulging discs.
PhotoMed’s team got surprising results that its anesthesiologist and neurologist advisors said could not be explained by current texts. 1 out of 3 people said that they felt better, but that was not very informative. This was frustrating because Intel wouldn’t pay the service bill if I told that their computer “feels better”.
It was easy to make a lamp that could emit any wavelength. So now I had a much bigger problem, what explains the medical change. We were missing the “how it works” presentation slide. We still cannot answer HOW it works, only precisely which second that it works based on thermal imaging.
Because the imaging shows an instantaneous change, conventional medical explanations are ruled out. This only leaves us, and theoretical physicists who have looked at this, with just one uncomfortable theory. A photon from a wavelength triggers the switch back from quantum imbalance to quantum equilibrium. Unfortunately, that’s faster than the speed of light. Or, as your grandmother might say, it was just going back-to-normal.
PhotoMed’s anesthesiologist and neurologist advisors suggested that this might represent a new branch of medicine.